Noonan Syndrome: Common Molecular Alterations and the Consequences

Area of Science:

• Genetics
• Oncology
• Pediatrics

Background:

• Noonan syndrome (NS) is a common autosomal dominant disorder.
• PTPN11 gene mutations are the most frequent molecular alteration in NS.
• PTPN11 encodes a protein tyrosine phosphatase involved in cell signaling.

Purpose of the Study:

• To present a case of Noonan syndrome with a PTPN11 mutation.
• To illustrate the classic clinical presentation of Noonan syndrome.
• To discuss the expected clinical follow-up for such cases.

Main Methods:

• Case report presentation.
• Review of clinical features associated with Noonan syndrome.
• Discussion of molecular alterations, specifically PTPN11 mutations.

Main Results:

• The presented case exhibited classic features of Noonan syndrome.
• A PTPN11 mutation was identified as the underlying molecular cause.
• The mutation is associated with an increased risk of malignancies, especially hematopoietic.

Conclusions:

• PTPN11 mutations are a significant factor in Noonan syndrome.
• Understanding the molecular basis aids in predicting associated health risks, including cancer.
• Clinical vigilance and follow-up are crucial for patients with Noonan syndrome and PTPN11 mutations.